Bibliografia
Online:
2. “ Fate and effects of acrolein”; Ghilarducci DP.,
Tjeerdema RS.; Santa Clara County Central Fire Protection District, Hazardous
Materials Program, Los Gatos, CA 95030, USA (artigo)
Online:
3. http://www.hclrss.demon.co.uk/acrolein.html
4. http://hazmap.nlm.nih.gov/cgi-bin/hazmap_generic?tbl=TblAgents&id=95
5. http://www.atsdr.cdc.gov/MHMI/mmg124.html
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
7. http://www.universal.pt/scripts/eum/eum.exe/DArtigo?texto=citologia&cod=314
17. EPA/635/R-03/003; TOXICOLOGICAL REVIEW OF ACROLEIN (CAS No. 107-02-8); In Support of Summary Information on the Integrated Risk Information System (IRIS) May 2003
Online:
http://www.epa.gov/iris/toxreviews/0364-tr.pdf
2. “ Fate and effects of acrolein”; Ghilarducci DP., Tjeerdema RS.; Santa Clara County Central Fire Protection District, Hazardous Materials Program, Los Gatos, CA 95030, USA (artigo)
Online:
4. http://hazmap.nlm.nih.gov/cgi-bin/hazmap_generic?tbl=TblAgents&id=95
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
13. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~kCGqpq:1
5. http://www.atsdr.cdc.gov/MHMI/mmg124.html
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
13. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~kCGqpq:1
14. Montgomery, J.H.; Agrochemicals Desk Reference 2nd ed. Lewis Publishers, Boca Raton, FL 1997,p.3-4
15. National Research Council. Prudent Practices for Handling
Hazardous Chemicals in Laboratories. Washington, DC: National Academy Press,
1981., p. 107
16.
Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.).
Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York,
NY: McGraw-Hill, 1996., p. 1676
17. EPA/635/R-03/003; TOXICOLOGICAL REVIEW OF ACROLEIN (CAS No. 107-02-8); In Support of Summary Information on the Integrated Risk Information System (IRIS) May 2003
Online:
http://www.epa.gov/iris/toxreviews/0364-tr.pdf
5. http://www.atsdr.cdc.gov/MHMI/mmg124.html
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
13. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~kCGqpq:1
17. EPA/635/R-03/003; TOXICOLOGICAL REVIEW OF ACROLEIN (CAS No. 107-02-8); In Support of Summary Information on the Integrated Risk Information System (IRIS) May 2003
Online:
http://www.epa.gov/iris/toxreviews/0364-tr.pdf
Efeitos em indivíduos susceptíveis
5. http://www.atsdr.cdc.gov/MHMI/mmg124.html
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
9. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~pMOdko:1
10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=
Abstract&list_uids=9718625&query_hl=1
5. http://www.atsdr.cdc.gov/MHMI/mmg124.html
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
9. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~pMOdko:1
11. http://www.state.nj.us/health/eoh/rtkweb/0021.pdf
12.
http://www.wynboer.co.za/recentarticles/1201bitter.php3
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
17. EPA/635/R-03/003; TOXICOLOGICAL REVIEW OF ACROLEIN (CAS No. 107-02-8); In Support of Summary Information on the Integrated Risk Information System (IRIS) May 2003
Online:
http://www.epa.gov/iris/toxreviews/0364-tr.pdf
18. CICAD (Concise International Chemical Assessment Document). (2002) Acrolein. Document 77 Number 43. Published under the joint sponsorship of the United Nations Environment Programme, the International Labour Organization, and the World Health Organization. World Health Organization, Geneva.
Online:
http://www.inchem.org/documents/cicads/cicads/cicad43.htm20. Arumugam, N; Thanislass, J; Ragunath, K; et al. (1999b) Acrolein-induced toxicity – defective mitochondrial function as a possible mechanism. Arch Environ Contam Toxicol 36(4):373-376.
21. “The Merck Índex” 30th Edition (2001)
22. TERA (Toxicology Excellence for Risk Assessment) (1998). ITER peer review meeting summary to review risk assessment documents on acrolein, acrylamide, and acrylonitrile.November 16-17, 1998
Online
http://www.tera.org/peer/nov98final.htm.
23. Timbrell JA. Principles of Biochemical Toxicology, 2nd ed. London, Taylor and Francis, 1991.
25. Prioritization of Toxic Air Contaminants - Children’s Environmental Health Protection Act October, 2001.
Online:
http://www.oehha.ca.gov/air/toxic_contaminants/pdf_zip/Acrolein_final.pdf
26. http://www.vet2pet.co.uk/default.asp?dogpoisonsaz.asp~mainframe
Acroleína vs toxicidade vascular
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
17. EPA/635/R-03/003; TOXICOLOGICAL REVIEW OF ACROLEIN (CAS No. 107-02-8); In Support of Summary Information on the Integrated Risk Information System (IRIS) May 2003
Online:
http://www.epa.gov/iris/toxreviews/0364-tr.pdf
27. Z. Yousefipour, K. Ranganna, M.A. Newaz, S.G. Milton; Mechanism of acrolein-induced vascular toxicity Journal of Physiology and Pharmacology 2005, 56, 3, 337–353
28. Cao Z, Hardej D, Trombetta LD, Trush MA, and Li Y. Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity. Atherosclerosis 2003; 166:291-301.
9. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~pMOdko:1
29. “The molecular effects of acrolein.”; Kehrer JP., Biswal SS.; Division of Pharmacology and Toxicology, College of Pharmacy, The University os Texas at Austin, Austin, Texas 78712, USA.
Online:
30. “Current status of acrolein as a lipid peroxidation
product”; Uchida K.; Laboratory of Food and Biodynamics, Nagoya University
Graduate School of Bioagricultural Science, Japan.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10639724&query_hl=1
31. [Grafstrom RC et al; Cancer Res 48(7): 1717-21 (1988)]
e
[Wilmer
JL et al; Cancer Res 46(1): 203-10 (1986)],
Online:
http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~pMOdko:1
Incertezas, dúvidas e controvérsias
Online:
6. http://www.atsdr.cdc.gov/toxprofiles/tp124.pdf
31. [Grafstrom RC et al; Cancer Res 48(7): 1717-21 (1988)]
e
[Wilmer
JL et al; Cancer Res 46(1): 203-10 (1986)],
Online:
http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~pMOdko:1
32. “Acrolein causes inhibitor kB- independent decreases in nuclear factor kB activation in human lung adenocarcinoma (A549) cells” - Horton et al_ 274 (14) 9200 - Journal of Biological Chemistry;
Online:
http://www.jbc.org/cgi/content/abstract/274/14/9200
Home O que é? Formas de Exposição Exposição aguda Exposição crónica
Efeitos em Indivíduos susceptíveis Recomendações Toxicocinética
Acroleína vs Asma Acroleína vs Toxicidade vascular Acroleína vs Citotoxicidade
Incertezas, dúvidas e Controvérsia Bibliografia